Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of NOL Index Intraoperative Guided Remifentanil Analgesia
Sponsor: Hopital Foch
Summary
The Physiological Monitoring Device (PMD-200™) system is comprised of a monitor and a designated finger probe containing 4 sensors. The sensors included are Photoplethysmography (PPG), Galvanic Skin Response (GSR), Accelerometer for movement (ACC) and Thermistor for peripheral temperature (TMP). The PMD-200 is intended to be used for assessing the nociception level in anesthetized patients. The purpose of the study is confirmation of a reduction in the dosage of remifentanil allowed by the monitoring of nociception by the NOL which could open the way to a double control of the administration of anesthetic agents: control of the administration of hypnotics by the bispectral index (BIS) and control of the administration of opiate by the NOL.
Official title: Impact of Nociceptive-Level (NOL) Intraoperative Guided Remifentanil Analgesia Versus Standard Clinical Care (SCC) for Elective Major Abdominal Surgery
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
210
Start Date
2021-04-13
Completion Date
2025-05
Last Updated
2024-06-14
Healthy Volunteers
No
Conditions
Interventions
Bispectral index
Anesthesia monitoring
Bispectral index + NOL index
Anesthesia monitoring
Locations (3)
Hôpital d'Instruction des Armées - Sainte-Anne
Toulon, Provence-Alpes-Côte d'Azur Region, France
Hopital d'Instruction des Armées de Bégin
Saint-Mandé, Saint Mandé, France
Foch Hospital
Suresnes, France